To include your compound in the COVID-19 Resource Center, submit it here.

Gentium falls after pulling defibrotide NDA

Gentium S.p.A. (NASDAQ:GENT) fell $1.94 (22%) to $6.85 on Thursday after

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE